MedPath

Magnesium hydroxide

Generic Name
Magnesium hydroxide
Brand Names
Almacone, Duo Fusion, Gelusil, Maalox Plus, Mi-acid, Mi-acid Double Strength, Mintox Plus, Mylanta, Mylanta Tonight, Pedia-lax Liquid, Pepcid Complete, Rolaids Advanced, Rolaids Reformulated Aug 2006, Rolaids Ultra Strength, Zegerid With Magnesium Hydroxide
Drug Type
Small Molecule
Chemical Formula
H2MgO2
CAS Number
1309-42-8
Unique Ingredient Identifier
NBZ3QY004S

Overview

Magnesium hydroxide is an inorganic compound. It is naturally found as the mineral brucite. Magnesium hydroxide can be used as an antacid or a laxative in either an oral liquid suspension or chewable tablet form. Additionally, magnesium hydroxide has smoke suppressing and flame retardant properties and is thus used commercially as a fire retardant. It can also be used topically as a deodorant or for the relief of canker sores (aphthous ulcers).

Background

Magnesium hydroxide is an inorganic compound. It is naturally found as the mineral brucite. Magnesium hydroxide can be used as an antacid or a laxative in either an oral liquid suspension or chewable tablet form. Additionally, magnesium hydroxide has smoke suppressing and flame retardant properties and is thus used commercially as a fire retardant. It can also be used topically as a deodorant or for the relief of canker sores (aphthous ulcers).

Indication

Magnesium hydroxide can be used as an antacid or a laxative depending on the administered dose. As an antacid, it is used for the temporary relief of heartburn, upset stomach, sour stomach or acid indigestion. As a laxative, it is used for the relief of occasional constipation by promoting bowel movements for 30 minutes and up to 6 hours.

Associated Conditions

  • Colic
  • Constipation
  • Dyspepsia
  • Flatulence
  • Gastric Ulcer
  • Heartburn
  • Upset stomach

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Geri-Care Pharmaceuticals, Corp
57896-001
ORAL
1200 mg in 15 mL
3/31/2025
Cardinal Health 107, LLC
55154-9429
ORAL
200 mg in 5 mL
5/1/2025
Geri-Care Pharmaceuticals, Corp
57896-004
ORAL
200 mg in 5 mL
3/31/2025
ATLANTIC BIOLOGICALS CORP.
17856-0630
ORAL
200 mg in 5 mL
5/12/2025
Geri-Care Pharmaceuticals, Corp
57896-002
ORAL
1200 mg in 15 mL
3/31/2025
ATLANTIC BIOLOGICALS CORP.
17856-5725
ORAL
400 mg in 5 mL
5/23/2025
Contract Pharmacal Corp.
10267-0041
ORAL
200 mg in 1 1
6/16/2025
Contract Pharmacal Corp.
10267-0020
ORAL
135 mg in 1 1
5/23/2025
ATLANTIC BIOLOGICALS CORP.
17856-0788
ORAL
1200 mg in 15 mL
5/23/2025
Chattem, Inc.
41167-0257
ORAL
600 mg in 1 1
3/31/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
AXCEL EVILINE FORTE SUSPENSION
SIN06400P
SUSPENSION
400 mg/5 ml
7/4/1991
HYDROSIL TABLET
SIN03484P
TABLET
200 mg
6/24/1989
MACGEL TABLET
SIN08119P
TABLET
200 mg
4/11/1995
ACTAL PLUS TABLET
SIN07376P
TABLET
152 mg
3/29/1993
GASTROGEL ANTACID
SIN02976P
SUSPENSION
24 mg/ml
5/26/1989
AXCEL EVILINE TABLET
SIN06592P
TABLET
200 mg
9/26/1991

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath